Fairman Jeff 4
4 · Vaxcyte, Inc. · Filed May 24, 2022
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Sale
Common Stock
2022-05-20$25.50/sh−4,112$104,856→ 321,227 total(indirect: By Trust)
Holdings
- 50,000(indirect: By Trust)
Common Stock
- 17,662
Common Stock
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Includes 1,033 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 17, 2022.